ASCENT-IBO supports multidisciplinary teams conducting Phase 1 and 2 ibogaine trials to establish safety and effectiveness for high-risk opioid use disorder and prepare for Phase 3 testing.
ASCENT-IBO now accepts submissions only from applicants who met previous deadline requirements; encouraged proposals are due by the assigned deadlines in Solution Summary feedback letters. New FAQs clarify eligibility, scope and budget requirements, and other application details also changed.
This grant supports clinical trials and research to improve pain management, addiction treatment, anesthesia safety, and drug prescribing practices.
Use existing data to analyze drug use behaviors, prevention strategies, and service utilization, aiming to advance substance use research.
Opioid Abatement (2026) supports North Carolina higher education researchers studying opioid prevention and remediation to develop practical, evidence-based guidance for state and local policy and practice.
This grant supports research using advanced single cell techniques to study how substance use disorders and HIV interact in the brain, aiming to uncover mechanisms and identify new therapy targets.
Supports high-risk, high-impact research on HIV and substance use to advance HIV prevention, diagnosis, treatment, and virus suppression among people who use substances or have substance use disorders.